SE0102404D0 - Novel immunomodulating compounds - Google Patents
Novel immunomodulating compoundsInfo
- Publication number
- SE0102404D0 SE0102404D0 SE0102404A SE0102404A SE0102404D0 SE 0102404 D0 SE0102404 D0 SE 0102404D0 SE 0102404 A SE0102404 A SE 0102404A SE 0102404 A SE0102404 A SE 0102404A SE 0102404 D0 SE0102404 D0 SE 0102404D0
- Authority
- SE
- Sweden
- Prior art keywords
- compound
- relates
- present
- immunomodulating compounds
- novel heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (22)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102404A SE0102404D0 (sv) | 2001-07-04 | 2001-07-04 | Novel immunomodulating compounds |
US10/179,731 US6642249B2 (en) | 2001-07-04 | 2002-06-26 | Immunomodulating compounds |
ES02746260T ES2258150T3 (es) | 2001-07-04 | 2002-07-02 | Compuestos inmunomodulares. |
CNB028132890A CN1249063C (zh) | 2001-07-04 | 2002-07-02 | 新颖的免疫调制性化合物 |
YU101603A YU101603A (en) | 2001-07-04 | 2002-07-02 | Novel immunomodulating compounds |
CA002451749A CA2451749A1 (en) | 2001-07-04 | 2002-07-02 | Novel immunomodulating compounds |
EP02746260A EP1409485B1 (de) | 2001-07-04 | 2002-07-02 | Immunmodulierende verbindungen |
PCT/SE2002/001309 WO2003004495A1 (en) | 2001-07-04 | 2002-07-02 | Novel immunomodulating compounds |
JP2003510662A JP2005501033A (ja) | 2001-07-04 | 2002-07-02 | 新規免疫調節性化合物 |
DE60210977T DE60210977T2 (de) | 2001-07-04 | 2002-07-02 | Immunmodulierende verbindungen |
BR0210776-7A BR0210776A (pt) | 2001-07-04 | 2002-07-02 | Compostos de imunomodulação |
AU2002315996A AU2002315996B2 (en) | 2001-07-04 | 2002-07-02 | Novel immunomodulating compounds |
AT02746260T ATE324373T1 (de) | 2001-07-04 | 2002-07-02 | Immunmodulierende verbindungen |
HU0401204A HUP0401204A3 (en) | 2001-07-04 | 2002-07-02 | Novel immunomodulating heterocondensated pyrazol-3-one derivatives and pharmaceutical compositions containing them |
RU2004103079/04A RU2004103079A (ru) | 2001-07-04 | 2002-07-02 | Новые иммуномодулирующие соединения |
MXPA04000017A MXPA04000017A (es) | 2001-07-04 | 2002-07-02 | Novedosos compuestos de inmunomodulacion. |
NZ530316A NZ530316A (en) | 2001-07-04 | 2002-07-02 | Novel immunomodulating compounds |
PL02367637A PL367637A1 (en) | 2001-07-04 | 2002-07-02 | Novel immunomodulating compounds |
HR20031055A HRP20031055B1 (en) | 2001-07-04 | 2003-12-17 | Novel immunomodulating compounds |
ZA200309806A ZA200309806B (en) | 2001-07-04 | 2003-12-19 | Novel immunomodulating compounds. |
NO20035684A NO20035684L (no) | 2001-07-04 | 2003-12-19 | Immunomodulerende forbindelser |
HK04109875A HK1066809A1 (en) | 2001-07-04 | 2004-12-14 | Novel immunomodulating compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102404A SE0102404D0 (sv) | 2001-07-04 | 2001-07-04 | Novel immunomodulating compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0102404D0 true SE0102404D0 (sv) | 2001-07-04 |
Family
ID=20284743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0102404A SE0102404D0 (sv) | 2001-07-04 | 2001-07-04 | Novel immunomodulating compounds |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1409485B1 (de) |
JP (1) | JP2005501033A (de) |
CN (1) | CN1249063C (de) |
AT (1) | ATE324373T1 (de) |
AU (1) | AU2002315996B2 (de) |
BR (1) | BR0210776A (de) |
CA (1) | CA2451749A1 (de) |
DE (1) | DE60210977T2 (de) |
ES (1) | ES2258150T3 (de) |
HK (1) | HK1066809A1 (de) |
HR (1) | HRP20031055B1 (de) |
HU (1) | HUP0401204A3 (de) |
MX (1) | MXPA04000017A (de) |
NO (1) | NO20035684L (de) |
NZ (1) | NZ530316A (de) |
PL (1) | PL367637A1 (de) |
RU (1) | RU2004103079A (de) |
SE (1) | SE0102404D0 (de) |
WO (1) | WO2003004495A1 (de) |
YU (1) | YU101603A (de) |
ZA (1) | ZA200309806B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006509047A (ja) * | 2002-11-22 | 2006-03-16 | アクティブ バイオテック アクチボラーグ | 免疫調節活性を有するピラゾロキノリン |
US7674906B2 (en) | 2002-12-16 | 2010-03-09 | Active Biotech Ab | Tetracyclic immunomodulatory compounds |
DE602004030225D1 (de) * | 2003-03-14 | 2011-01-05 | Medigene Ltd | Immunmodulierende heterocyclische verbindungen |
GB0305876D0 (en) * | 2003-03-14 | 2003-04-16 | Avidex Ltd | Immuno inhibitory heterocyclic compounds |
GB0325644D0 (en) | 2003-11-04 | 2003-12-10 | Avidex Ltd | Immuno ihibitory pyrazolone compounds |
EP1707567A4 (de) * | 2004-01-14 | 2009-08-19 | Ajinomoto Kk | Neue verbindung mit kondensiertem ring |
GB0411770D0 (en) | 2004-05-26 | 2004-06-30 | Avidex Ltd | Immuno inhibitory heterocyclic compouds |
US7932253B2 (en) | 2004-08-09 | 2011-04-26 | Medigene Ag | Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors |
CN101863903B (zh) * | 2010-06-08 | 2014-03-12 | 沈阳药科大学 | 1,4-二氢噻吩并[3’,2’:5,6]噻喃并[4,3-c]吡唑-3-羧酸衍生物及其应用 |
RU2663898C2 (ru) * | 2013-06-24 | 2018-08-13 | Мерк Патент Гмбх | Пиразольные соединения в качестве модуляторов fshr и их применение |
EP2883883A1 (de) | 2013-12-16 | 2015-06-17 | Cardio3 Biosciences S.A. | Therapeutische Ziele und Mittel zur Behandlung von ischämiebedingten Reperfusionsschäden |
EA035074B9 (ru) | 2014-07-08 | 2020-05-15 | Авертана Лимитед | Извлечение продукции из титансодержащих минералов |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4268516A (en) * | 1978-10-11 | 1981-05-19 | Pfizer Inc. | [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents |
US4312870A (en) * | 1979-06-21 | 1982-01-26 | Ciba-Geigy Corporation | Pyrazoloquinolines |
ZA895646B (en) * | 1988-08-09 | 1990-04-25 | Boots Co Plc | Therapeutic agents |
GB8818895D0 (en) * | 1988-08-09 | 1988-09-14 | Boots Co Plc | Therapeutic agents |
SE8903564D0 (sv) * | 1989-10-26 | 1989-10-26 | Pharmacia Ab | New use condensed quinoline compound |
EP0539372A1 (de) * | 1990-02-02 | 1993-05-05 | The Boots Company PLC | Therapeutische mittel |
ID16283A (id) * | 1996-03-20 | 1997-09-18 | Astra Pharma Prod | Senyawa yang berguna dibidang farmasi |
-
2001
- 2001-07-04 SE SE0102404A patent/SE0102404D0/xx unknown
-
2002
- 2002-07-02 ES ES02746260T patent/ES2258150T3/es not_active Expired - Lifetime
- 2002-07-02 CN CNB028132890A patent/CN1249063C/zh not_active Expired - Fee Related
- 2002-07-02 EP EP02746260A patent/EP1409485B1/de not_active Expired - Lifetime
- 2002-07-02 AT AT02746260T patent/ATE324373T1/de not_active IP Right Cessation
- 2002-07-02 RU RU2004103079/04A patent/RU2004103079A/ru not_active Application Discontinuation
- 2002-07-02 YU YU101603A patent/YU101603A/sh unknown
- 2002-07-02 HU HU0401204A patent/HUP0401204A3/hu unknown
- 2002-07-02 AU AU2002315996A patent/AU2002315996B2/en not_active Ceased
- 2002-07-02 MX MXPA04000017A patent/MXPA04000017A/es active IP Right Grant
- 2002-07-02 PL PL02367637A patent/PL367637A1/xx not_active Application Discontinuation
- 2002-07-02 NZ NZ530316A patent/NZ530316A/en unknown
- 2002-07-02 CA CA002451749A patent/CA2451749A1/en not_active Abandoned
- 2002-07-02 JP JP2003510662A patent/JP2005501033A/ja not_active Withdrawn
- 2002-07-02 WO PCT/SE2002/001309 patent/WO2003004495A1/en active IP Right Grant
- 2002-07-02 BR BR0210776-7A patent/BR0210776A/pt not_active IP Right Cessation
- 2002-07-02 DE DE60210977T patent/DE60210977T2/de not_active Expired - Lifetime
-
2003
- 2003-12-17 HR HR20031055A patent/HRP20031055B1/xx not_active IP Right Cessation
- 2003-12-19 ZA ZA200309806A patent/ZA200309806B/en unknown
- 2003-12-19 NO NO20035684A patent/NO20035684L/no not_active Application Discontinuation
-
2004
- 2004-12-14 HK HK04109875A patent/HK1066809A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1409485A1 (de) | 2004-04-21 |
RU2004103079A (ru) | 2005-06-10 |
AU2002315996B2 (en) | 2007-11-29 |
YU101603A (en) | 2006-05-25 |
ES2258150T3 (es) | 2006-08-16 |
ATE324373T1 (de) | 2006-05-15 |
HK1066809A1 (en) | 2005-04-01 |
HRP20031055B1 (en) | 2008-01-31 |
DE60210977T2 (de) | 2006-09-21 |
CN1249063C (zh) | 2006-04-05 |
ZA200309806B (en) | 2004-12-20 |
CA2451749A1 (en) | 2003-01-16 |
HUP0401204A3 (en) | 2008-03-28 |
NZ530316A (en) | 2004-08-27 |
CN1522254A (zh) | 2004-08-18 |
DE60210977D1 (de) | 2006-06-01 |
NO20035684D0 (no) | 2003-12-19 |
PL367637A1 (en) | 2005-03-07 |
EP1409485B1 (de) | 2006-04-26 |
NO20035684L (no) | 2004-03-02 |
WO2003004495A1 (en) | 2003-01-16 |
BR0210776A (pt) | 2004-07-20 |
HRP20031055A2 (en) | 2004-06-30 |
HUP0401204A2 (hu) | 2004-10-28 |
JP2005501033A (ja) | 2005-01-13 |
MXPA04000017A (es) | 2004-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1086562A1 (en) | Pyrazoloquinolines with immunomodulating activity | |
MX2021001433A (es) | Nuevos compuestos heterociclicos como inhibidores de la monoacilglicerol lipasa. | |
HK1067120A1 (en) | Glutaminyl based dpiv inhibitors | |
BR0311343A (pt) | Derivados de piridazina | |
WO2005092895A3 (en) | Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists | |
SE0102404D0 (sv) | Novel immunomodulating compounds | |
WO2008045393A3 (en) | Imidazo- and triazolo-pyridine compounds and methods of use therof | |
WO2004074244A3 (en) | Pyrimidine compounds | |
BR0306566B1 (pt) | mÉtodo para fabricar escària contendo àxido de titÂnio. | |
HK1061846A1 (en) | New process for the industrial synthesis of substituted thiophenecarboxylates, and application of such compounds | |
ZA200404752B (en) | 6-aminomorphinane derivatives method for the production and use thereof | |
SE0200919D0 (sv) | Chemical compounds | |
WO2003087062A3 (en) | 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation | |
WO2005009951A3 (en) | Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use | |
MXPA05007607A (es) | Inhibidores amida y ester de la metaloproteinasa de matriz. | |
WO2004007664A3 (en) | Nucleic acid vectors | |
WO2006079720A8 (fr) | Nouveaux derives d1oximes heterocycliques, leur procede de preparation et leur utilisation comme agents hypoglycemiants et hypoli pemiants | |
ATE425164T1 (de) | Tetrazyklische immunmodulierende verbindungen | |
TR200503401T1 (tr) | Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları | |
HK1061845A1 (en) | New process for the industrial synthesis of substituted thiophenecarboxylates, and application of such compounds | |
GB0412314D0 (en) | Compounds | |
WO2004024060A3 (en) | Metalloproteinase inhibitors and intermediates for preparation thereof | |
ATE327987T1 (de) | Methylthiophencarboxanilide | |
DK1513833T3 (da) | Nye forbindelser af 3-(4-oxo-4H-chromen-2-yl)-(1H)-quinolin-4-on, fremgangsmåde til fremstilling af samme samt farmaceutiske sammensætninger indeholdende samme | |
WO2007009080A3 (en) | Ppar [alpha/gamma] agonists and processes of preparing |